Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury

Journal of Neurotrauma

Volumn 33, Issue 2, 2016, Pages 215-225

  Korley, Frederick K ^a   Diaz Arrastia, Ramon ^b   Wu, Alan H B ^c   Yue, John K ^d   Manley, Geoffrey T ^d   Sair, Haris I ^a   Van Eyk, Jennifer ^e   Everett, Allen D ^a   Okonkwo, David O ^f   Valadka, Alex B ^g   Gordon, Wayne A ^h   Maas, Andrew I R ⁱ   Mukherjee, Pratik ^j   Yuh, Esther L ^j   Lingsma, Hester F ^k   Puccio, Ava M ^f   Schnyer, David M ^l  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g Seton Brain and Spine Institute   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Center for Medical Decision Making   (Netherlands)

^l UNIVERSITY OF TEXAS AT AUSTIN   (United States)

more..

Author keywords

biomarkers; brain derived neurotrophic factor; glial fibrillary acidic protein; traumatic brain injury; ubiquitin C terminal hydrolase L1

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN CONCUSSION; CLINICAL EVALUATION; CONCENTRATION PROCESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; CASE CONTROL STUDY; CLINICAL TRIAL; CONVALESCENCE; MIDDLE AGED; PHYSIOLOGY; RANDOMIZATION; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY;

ADULT; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX;

EID: 84954316295     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2015.3949     Document Type: Article

References (69)

1. Papa, L., Lewis, L. M., Falk, J. L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G. M., Demery, J. A., Dixit, N. K., Ferguson, I., Liu, M. C., Mo, J., Akinyi, L., Schmid, K., Mondello, S., Robertson, C. S., Tortella, F. C., Hayes, R. L., and Wang, K. K. (2012). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483.
2. Mondello, S., Jeromin, A., Buki, A., Bullock, R., Czeiter, E., Kovacs, N., Barzo, P., Schmid, K., Tortella, F., Wang, K. K., and Hayes, R. L. (2012). Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J. Neurotrauma. 29, 1096-1104.
3. Mondello, S., Gabrielli, A., Catani, S., D'Ippolito, M., Jeromin, A., Ciaramella, A., Bossu, P., Schmid, K., Tortella, F., Wang, K. K., Hayes, R. L., and Formisano, R. (2012). Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury. Brain Inj. 26, 1629-1635.
4. Shahim, P., Tegner, Y., Wilson, D. H., Randall, J., Skillback, T., Pazooki, D., Kallberg, B., Blennow, K., and Zetterberg, H. (2014). Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 71, 684-692.
5. Diaz-Arrastia, R.,Kochanek, P. M., Bergold, P., Kenney,K., Marx, C. E., Grimes, C. J., Loh, L. T., Adam, L. T., Oskvig, D., Curley, K. C., and Salzer, W. (2014). Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J. Neurotrauma. 31, 135-158.
6. Cohen-Cory, S., Kidane, A. H., Shirkey, N. J., and Marshak, S. (2010). Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 70, 271-288.
7. Huang, E. J. and Reichardt, L. F. (2001). Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736.
8. Alonso, M., Vianna, M. R., Depino, A. M., Mello, E.S., Pereira, P., Szapiro, G., Viola, H., Pitossi, F., Izquierdo, I., and Medina, J. H. (2002). BDNF-Triggered events in the rat hippocampus are required for both short- And long-Term memory formation. Hippocampus. 12, 551-560.
9. Bekinschtein, P., Cammarota, M., Izquierdo, I., and Medina, J. H. (2008). BDNF and memory formation and storage. Neuroscientist. 14, 147-156.
10. Kaplan, G. B., Vasterling, J. J., and Vedak, P. C. (2010). Brain-derived neurotrophic factor in traumatic brain injury, post-Traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav. Pharmacol. 21, 427-437.
11. Sofroniew, M. V., Howe, C. L., and Mobley, W. C. (2001). Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217-1281.
12. Zhou, Z., Chen, H., Zhang, K., Yang, H., Liu, J., and Huang, Q. (2003). Protective effect of nerve growth factor on neurons after traumatic brain injury. J. Basic Clin. Physiol. Pharmacol. 14, 217-224.
13. Hol, E. M. and Pekny, M. (2015). Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell. Biol. 32, 121-130.
14. Vos, P. E., Jacobs, B., Andriessen, T. M., Lamers, K. J., Borm, G. F., Beems, T., Edwards, M., Rosmalen, C. F., and Vissers, J. L. (2010). GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology. 75, 1786-1793.
15. Okonkwo, D. O., Yue, J. K., Puccio, A. M., Panczykowski, D. M., Inoue, T., McMahon, P. J., Sorani, M. D., Yuh, E. L., Lingsma, H. F., Maas, A. I., Valadka, A. B., and Manley, G. T. (2013). GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. J. Neurotrauma. 30, 1490-1497.
16. Pelinka, L. E.,Kroepfl, A., Schmidhammer, R., Krenn, M., Buchinger, W., Redl, H., and Raabe, A. (2004). Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma. 57, 1006-1012.
17. Mondello, S., Linnet, A., Buki, A., Robicsek, S., Gabrielli, A., Tepas, J., Papa, L., Brophy, G. M., Tortella, F., Hayes, R. L., and Wang, K. K. (2012). Clinical utility of serum levels of ubiquitin C-Terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery. 70, 666-675.
18. Diaz-Arrastia, R., Wang, K. K., Papa, L., Sorani, M. D., Yue, J. K., Puccio, A. M., McMahon, P. J., Inoue, T., Yuh, E. L., Lingsma, H. F., Maas, A. I., Valadka, A. B., Okonkwo, D. O., and Manley, G. T. (2014). Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-Terminal hydrolase-L1 and glial fibrillary acidic protein. J. Neurotrauma. 31, 19-25.
19. Papa, L.,Akinyi, L., Liu,M.C., Pineda, J.A., Tepas, J. J.,3rd.,Oli, M. W., Zheng, W., Robinson, G., Robicsek, S. A., Gabrielli, A., Heaton, S. C., Hannay, H. J., Demery, J. A., Brophy, G. M., Layon, J., Robertson, C. S., Hayes, R. L., and Wang, K. K. (2010). Ubiquitin C-Terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38, 138-144.
20. Yue, J. K., Vassar, M. J., Lingsma, H. F., Cooper, S. R., Okonkwo, D. O., Valadka, A. B., Gordon, W. A., Maas, A. I., Mukherjee, P., Yuh, E. L., Puccio, A. M., Schnyer, D. M., and Manley, G. T. (2013). Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J. Neurotrauma. 30, 1831-1844.
21. Jagoda, A. S., Bazarian, J. J., Bruns, J. J., Jr, Cantrill, S. V., Gean, A. D., Howard, P. K., Ghajar, J., Riggio, S., Wright, D. W., Wears, R. L., Bakshy, A., Burgess, P., Wald, M. M., and Whitson, R.R.; American College of Emergency Physicians; Centers for Disease Control and Prevention. (2008). Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann. Emerg. Med. 52, 714-748.
22. Menon, D. K., Schwab, K., Wright, D. W., and Maas, A. I. (2010). Position statement: definition of traumatic brain injury. Arch. Phys. Med. Rehabil. 91, 1637-1640.
23. Korley, F. K., Schulman, S. P., Sokoll, L. J., DeFilippis, A. P., Stolbach, A. I., Bayram, J. D., Saheed, M. O., Omron, R., Fernandez, C., Lwin, A., Cai, S. S., Post, W. S., and Jaffe, A. S. (2014). Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance. Acad. Emerg. Med. 21, 727-735.
24. Manley, G. T., Diaz-Arrastia, R., Brophy, M., Engel, D., Goodman, C., Gwinn, K., Veenstra, T. D., Ling, G., Ottens, A. K., Tortella, F., and Hayes, R. L. (2010). Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch. Phys. Med. Rehabil. 91, 1667-1672.
25. Gutierrez, S., Bembea, M., Everett, A., and Schwartz, J. (2014). Impact of delayed blood sample processing on brain injury biomarker stability [Abstract 533]. Crit. Care Med. 42(12 Suppl), A1488.
26. Apple, F. S., Quist, H. E., Doyle, P. J., Otto,A. P., and Murakami,M.M. (2003). Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/ American College of Cardiology consensus recommendations. Clin. Chem. 49, 1331-1336.
27. Apple, F. S., Parvin, C. A., Buechler, K. F., Christenson, R. H., Wu, A. H., and Jaffe, A. S. (2005). Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin. Chem. 51, 2198-2200.
28. Duhaime, A. C., Gean, A. D., Haacke, E.M., Hicks, R.,Wintermark, M., Mukherjee, P., Brody, D., Latour, L., and Riedy, G. (2010). Common data elements in radiologic imaging of traumatic brain injury. Arch. Phys. Med. Rehabil. 91, 1661-1666.
29. King, N. S., Crawford, S., Wenden, F. J., Moss, N. E., and Wade, D. T. (1995). The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J. Neurol. 242, 587-592.
30. Babcock, L., Byczkowski, T., Wade, S. L., Ho, M., Mookerjee, S., and Bazarian, J. J. (2013). Predicting postconcussion syndrome after mild traumatic brain injury in children and adolescents who present to the emergency department. JAMA Pediatr. 167, 156-161.
31. Levin, H. S., Boake, C., Song, J., Mccauley, S., Contant, C., Diaz- Marchan, P., Brundage, S., Goodman, H., and Kotrla, K. J. (2001). Validity and sensitivity to change of the extended Glasgow Outcome Scale in mild to moderate traumatic brain injury. J. Neurotrauma. 18, 575-584.
32. O'Neil, M. E., Carlson, K., Storzbach, D., Brenner, L., Freeman, M., Quinones, A., Motu'apuaka, M., Ensley, M., and Kansagara, D. (2013). Complications of Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review [Internet]. Washington (DC): Department of Veterans Affairs (US). VA Evidence-based Synthesis Program Reports
33. DeLong, E. R., DeLong, D. M., and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44, 837-845.
34. Golden, E., Emiliano, A., Maudsley, S., Windham, B. G., Carlson, O. D., Egan, J. M., Driscoll, I., Ferrucci, L., Martin, B., and Mattson, M. P. (2010). Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One. 5, e10099.
35. Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff-Werner, P., and Virchow, J. C. (2005). The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging. 26, 115-123.
36. Nieto, R., Kukuljan, M., and Silva, H. (2013). BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front. Psychiatry 4:45.
37. Fidalgo, T. M., Morales-Quezada, J. L., Muzy, G. S., Chiavetta, N. M., Mendonca, M. E., Santana, M. V., Goncalves, O. F., Brunoni, A. R., and Fregni, F. (2013). Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review. J. ECT. 30, 47-61.
38. Steyerberg, E. W., Eijkemans, M. J., and Habbema, J. D. (1999). Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J. Clin. Epidemiol. 52, 935-942.
39. Oyesiku, N. M., Evans, C. O., Houston, S., Darrell, R. S., Smith, J. S., Fulop, Z. L., Dixon, C. E., and Stein, D. G. (1999). Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain. Brain Res. 833, 161-172.
40. Felderhoff-Mueser, U., Sifringer, M., Pesditschek, S., Kuckuck, H., Moysich, A., Bittigau, P., and Ikonomidou, C. (2002). Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol. Dis. 11, 231-245.
41. Yang, K., Perez-Polo, J. R., Mu, X. S., Yan, H. Q., Xue, J. J., Iwamoto, Y., Liu, S. J., Dixon, C. E., and Hayes, R. L. (1996). Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury. J. Neurosci. Res. 44, 157-164.
42. Wu, A., Ying, Z., and Gomez-Pinilla, F. (2004). Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma. 21, 1457-1467.
43. Chiaretti, A., Piastra, M., Polidori, G., Di Rocco, C., Caresta, E., Antonelli, A., Amendola, T., and Aloe, L. (2003). Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med. 29, 1329-1338.
44. Chiaretti, A., Antonelli, A., Riccardi, R., Genovese, O., Pezzotti, P., Di Rocco, C., Tortorolo, L., and Piedimonte, G. (2008). Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children. Eur. J. Paediatr. Neurol. 12, 195-204.
45. Neselius, S., Brisby, H., Theodorsson, A., Blennow, K., Zetterberg, H., and Marcusson, J. (2012). CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One. 7, e33606.
46. Buonora, J. E., Yarnell, A. M., Lazarus, R. C., Mousseau, M., Latour, L. L., Rizoli, S. B., Baker, A. J., Rhind, S. G., Diaz-Arrastia, R., and Mueller, G. P. (2015). Multivariate analysis of traumatic brain injury: development of an assessment score. Front. Neurol. 6, 68.
47. Kalish, H. and Phillips, T. M. (2010). Analysis of neurotrophins in human serum by immunoaffinity capillary electrophoresis (ICE) following traumatic head injury. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878, 194-200.
48. Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., and Barde, Y. A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9, 2459-2464.
49. Zetterberg, H., Smith, D. H., and Blennow, K. (2013). Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat. Rev. Neurol. 9, 201-210.
50. Radka, S. F., Holst, P. A., Fritsche, M., and Altar, C. A. (1996). Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 709, 122-301.
51. Shulga, A., Thomas-Crusells, J., Sigl, T., Blaesse, A., Mestres, P., Meyer, M., Yan, Q., Kaila, K., Saarma, M., Rivera, C., and Giehl, K. M. (2008). Posttraumatic GABA(A)-mediated Ca2 + ]i increase is essential for the induction of brain-derived neurotrophic factor-dependent survival of mature central neurons. J. Neurosci. 28, 6996-7005.
52. Kim, D. H. and Zhao, X. (2005). BDNF protects neurons following injury by modulation of caspase activity. Neurocrit. Care. 3, 71-76.
53. Rudge, J. S., Mather, P. E., Pasnikowski, E. M., Cai, N., Corcoran, T., Acheson, A., Anderson, K., Lindsay, R. M., and Wiegand, S. J. (1998). Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp. Neurol. 149, 398-410.
54. Koh, J. Y., Gwag, B. J., Lobner, D., and Choi, D. W. (1995). Potentiated necrosis of cultured cortical neurons by neurotrophins. Science. 268, 573-575.
55. Suliman, S., Hemmings, S. M., and Seedat, S. (2013). Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front. Integr. Neurosci. 7, 55.
56. Brunoni, A. R., Lopes, M., and Fregni, F. (2008) A systematic review and meta-Analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11, 1169-1180.
57. Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., and Carr, V. J. (2011). Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-Analysis. Mol. Psychiatry. 16, 960-972.
58. Yamada, K. and Nabeshima, T. (2003). Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267-270.
59. Yamamoto, H. and Gurney, M. E. (1990). Human platelets contain brain-derived neurotrophic factor. J. Neurosci. 10, 3469-3478.
60. Fujimura, H., Altar, C. A., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J., Sun, B., and Tandon, N. N. (2002). Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 87, 728-734.
61. Lommatzsch, M., Braun, A., Mannsfeldt, A., Botchkarev, V. A., Botchkareva, N. V., Paus, R., Fischer, A., Lewin, G. R., and Renz, H. (1999). Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am. J. Pathol. 155, 1183-1193.
62. Helan, M., Aravamudan, B., Hartman, W. R., Thompson, M. A., Johnson, B. D., Pabelick, C. M., and Prakash, Y. S. (2014). BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia. J. Mol. Cell. Cardiol. 68, 89-97.
63. Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., and Kastin, A. J. (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 37, 1553-1561.
64. Karege, F., Schwald, M., and Cisse, M. (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261-264.
65. Griesbach, G. S., Hovda, D. A., Molteni, R., Wu, A., and Gomez- Pinilla, F. (2004). Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience. 125, 129-139.
66. Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., Rockenstein, E., Chao, M. V., Koo, E. H., Geschwind, D., Masliah, E., Chiba, A. A., and Tuszynski, M. H. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 15, 331-337.
67. Griesbach, G. S., Hovda, D. A., Molteni, R., Wu, A., and Gomez- Pinilla, F. (2004). Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience. 125, 129-139.
68. Korley, F. K., Morton, M. J., Hill, P. M., Mundangepfupfu, T., Zhou, T., Mohareb, A. M., and Rothman, R. E. (2013). Agreement between routine emergency department care and clinical decision support recommended care in patients evaluated for mild traumatic brain injury. Acad. Emerg. Med. 20, 463-469.
69. Papa, L., Stiell, I. G., Clement, C.M., Pawlowicz, A., Wolfram, A., Braga, C., Draviam, S., and Wells, G. A. (2012). Performance of the Canadian CT Head Rule and the New Orleans Criteria for predicting any traumatic intracranial injury on computed tomography in a United States Level I trauma center. Acad. Emerg. Med. 19, 2-10.